Table 4 Standardised prevalence of chronic diseases in patients with COPD

Congestive heart failure

8.03

3.34

2.41

1.88

2.93

Chronic liver disease

4.99

2.63

1.89

1.37

2.42

Asthma

5.83

3.36

1.73

1.29

2.18

Generalised atherosclerosis

10.47

6.25

1.67

1.35

1.99

Osteoporosis

6.98

4.91

1.42

1.09

1.75

Ischaemic heart disease

8.45

6.00

1.41

1.11

1.71

Schizophrenia

1.15

0.85

1.35

0.57

2.12

Thyroid disease

14.21

11.06

1.28

1.07

1.50

Chronic renal failure

6.34

4.96

1.28

0.96

1.59

Anxiety/Depression

20.20

15.86

1.27

1.10

1.45

Cardiac valve disease

2.21

1.76

1.25

0.73

1.77

Cardiac arrhythmia

15.81

12.70

1.25

1.05

1.44

Obesity

25.32

20.49

1.24

1.08

1.39

Chronic skin ulcer

2.37

1.96

1.20

0.72

1.69

Glaucoma

5.31

4.51

1.18

0.86

1.46

Cerebrovascular disease

7.49

6.48

1.16

0.89

1.42

Diabetes mellitus

20.77

18.24

1.14

0.98

1.29

Degenerative joint disease

5.67

5.11

1.11

0.82

1.40

Malignant neoplasms

12.90

11.63

1.11

0.92

1.30

Disorders of lipid metabolism

34.44

31.32

1.10

0.98

1.22

Arterial hypertension

51.98

48.14

1.08

0.99

1.17

Deafness, hearing loss

8.19

7.87

1.04

0.82

1.27

Parkinson’s disease

1.66

1.71

0.97

0.50

1.44

Benign prostatic hypertrophy

15.81

16.41

0.96

0.81

1.11

Dementias

1.92

2.56

0.75

0.41

1.08